1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow GVHD (Acute or Chronic): new trials by email Literature Review of GVHD (Acute or Chronic) trials Research Report on GVHD (Acute or Chronic)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children 1mg /kg VIC-1911 - GVHD (Acute or Chronic) | Phase 1 | Recruiting | Shanghai Jiao Tong University School of Medicine | 9 | 2026-09-28 | 2026-10-20 |
| Phase I Study of Milatuzumab for Graft Versus Host Disease milatuzumab - GVHD (Acute or Chronic), Acute Myeloid or Lymphoblastic Leukemia (AML or ALL) | Phase 1 | Terminated | Gilead Sciences | 12 | 2013-12-01 | 2021-08-19 |
Bronchiolitis Obliterans Syndrome (2) · Graft vs Host Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Bronchial Diseases (2) · Bronchiolitis (2) · Bronchiolitis Obliterans (2) · Bronchitis (2) · Immune System Diseases (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Organizing Pneumonia (2) · Respiratory Tract Diseases (2) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1)
milatuzumab (1)
Gilead Sciences (1) · Shanghai Jiao Tong University School of Medicine (1)
China (1) · United States (1)